Outcome of metastatic breast cancer in selected women with or without deleterious BRCA mutations

By Bayraktar S.  

Clinical and Experimental Metastasis, Vol. 30, Iss. 5, 2013-06 ,pp. : 631-642

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of BRCA Mutations Among Women with Triple-Negative Breast Cancer (TNBC) in a Genetic Counseling Cohort

By Greenup Rachel   Buchanan Adam   Lorizio Wendy   Rhoads Keelia   Chan Salina   Leedom Tracey   King Robin   McLennan Jane   Crawford Beth   Kelly Marcom P.   Shelley Hwang E.  

Annals of Surgical Oncology, Vol. 20, Iss. 10, 2013-10 ,pp. : 3254-3258

Springer Publishing Company

Access to resources Recommend Favorite

Novel BRCA1 deleterious mutation (c.1949_1950delTA) in a woman of Senegalese descent with triple-negative early-onset breast cancer

By                  

Oncology Letters, Vol. 2, Iss. 6, 2011-01 ,pp. : 1287-1289

Spandidos Publications

Access to resources Recommend Favorite

Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women

By Comen E.   Davids M.   Kirchhoff T.   Hudis C.   Offit K.   Robson M.  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite

BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy

By Foedermayr Mathilde   Sebesta Miriam   Rudas Margaretha   Berghoff Anna   Promberger Regina   Preusser Matthias   Dubsky Peter   Fitzal Florian   Gnant Michael   Steger Guenther   Weltermann Ansgar   Zielinski Christoph   Zach Otto   Bartsch Rupert  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 771-778

Springer Publishing Company

Access to resources Recommend Favorite